Annotation Detail for DPYD
Basic Information Top
Gene Symbol: | DPYD ( DHP,DHPDHASE,DPD,MGC132008,MGC70799 ) |
---|---|
Gene Full Name: | dihydropyrimidine dehydrogenase |
Band: | 1p21.3 |
Quick Links | Entrez ID:1806; OMIM: 612779; Uniprot ID:DPYD_HUMAN; ENSEMBL ID: ENSG00000188641; HGNC ID: 3012 |
Relate to Another Database: | SFARIGene; denovo-db |
No data |
Pathway ID | Pathway Name |
---|---|
hsa00240 | Pyrimidine metabolism |
hsa00410 | beta-Alanine metabolism |
hsa00770 | Pantothenate and CoA biosynthesis |
hsa00983 | Drug metabolism - other enzymes |
hsa01100 | Metabolic pathways |
Pathway ID | Pathway Name |
---|---|
Metabolism of nucleotides |
No data |
Pathway ID | Pathway Name |
---|---|
P02771 | Pyrimidine Metabolism |
Pathway ID | Pathway Name |
---|---|
500232 | Pyrimidine catabolism |
Desease ID | Desease Name |
---|---|
H00193 | Dihydropyrimidine dehydrogenase deficiency |
Inherited disorders of nucleotide metabolism | |
Genetic disorders |
No data |
Desease Name |
---|
5-flurouracil toxicity |
PHARMACOGENOMIC |
5-fluorouracil toxicity |
5-fluorouracil- related toxicity |
No data |
Desease Name |
---|
5-fluorouracil toxicity |
Dihydropyrimidine dehydrogenase deficiency |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C031903 | 1-UFT protocol | DPYD protein results in decreased susceptibility to 1-UFT protocol | decreases response to substance | 16734730 |
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of DPYD mRNA | affects expression | 21346803 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene results in decreased expression of DPYD mRNA | decreases expression | 20406850 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of DPYD mRNA | affects expression | 21346803 |
C019499 | 2-nitrofluorene | 2-nitrofluorene results in decreased expression of DPYD mRNA | decreases expression | 15890375 |
C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in increased expression of DPYD mRNA | increases expression | 18648102 |
C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of DPYD mRNA | decreases expression | 15890375 |
C029269 | 5-fluoropyrimidine | DPYD gene polymorphism results in increased susceptibility to 5-fluoropyrimidine | increases response to substance | 18633250 |
D000082 | Acetaminophen | Acetaminophen affects the expression of DPYD mRNA | affects expression | 17562736 |
D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of DPYD protein | affects expression | 20106945 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of DPYD mRNA | decreases expression | 15890375 |
D000638 | Amiodarone | Amiodarone affects the expression of DPYD mRNA | affects expression | 19483382 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of DPYD mRNA | affects expression | 16483693 |
D001374 | Azacitidine | Azacitidine results in decreased methylation of DPYD promoter | decreases methylation | 15501990 |
D001374 | Azacitidine | [Azacitidine results in decreased methylation of DPYD promoter] which results in increased expression of DPYD mRNA | decreases methylation|increases expression | 15501990 |
D001374 | Azacitidine | DPYD protein results in decreased susceptibility to Azacitidine | decreases response to substance | 15501990 |
D001553 | Benzbromarone | Benzbromarone affects the expression of DPYD mRNA | affects expression | 19483382 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of DPYD mRNA | decreases expression | 20106945 20064835 |
D002166 | Camptothecin | Camptothecin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA] | decreases reaction|increases expression | 16568373 |
D002166 | Camptothecin | Camptothecin results in decreased activity of DPYD protein | decreases activity | 16568373 |
D002166 | Camptothecin | Camptothecin results in decreased expression of DPYD mRNA | decreases expression | 16568373 |
C110904 | capecitabine | capecitabine results in increased expression of DPYD mRNA | increases expression | 17611699 |
C110904 | capecitabine | DPYD protein affects the susceptibility to capecitabine | affects response to substance | 18846242 |
C110904 | capecitabine | DPYD protein results in decreased susceptibility to capecitabine | decreases response to substance | 16734730 |
D002994 | Clofibrate | Clofibrate affects the expression of DPYD mRNA | affects expression | 19483382 |
D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DPYD mRNA | affects cotreatment|affects expression | 17602206 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of DPYD mRNA | decreases expression | 20106945 |
C014347 | decitabine | decitabine results in decreased methylation of DPYD promoter | decreases methylation | 17612628 |
C014347 | decitabine | decitabine results in increased expression of DPYD mRNA | increases expression | 17612628 |
D016190 | Carboplatin | PCNA mRNA affects the reaction [DPYD mRNA affects the susceptibility to Carboplatin] | affects reaction|affects response to substance | 16685392 |
D002945 | Cisplatin | [Cisplatin co-treated with Fluorouracil] results in decreased expression of DPYD mRNA | affects cotreatment|decreases expression | 15737843 |
D002945 | Cisplatin | Cisplatin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA] | decreases reaction|increases expression | 16568373 |
D002945 | Cisplatin | Cisplatin results in decreased activity of DPYD protein | decreases activity | 16568373 |
D002945 | Cisplatin | Cisplatin results in decreased expression of DPYD mRNA | decreases expression | 16568373 |
D002945 | Cisplatin | DPYD protein affects the susceptibility to Cisplatin | affects response to substance | 18728667 |
D002945 | Cisplatin | PCNA mRNA affects the reaction [DPYD mRNA affects the susceptibility to Cisplatin] | affects reaction|affects response to substance | 16685392 |
D002945 | Cisplatin | [TYMP protein co-treated with DPYD protein] affects the susceptibility to Cisplatin | affects cotreatment|affects response to substance | 18728667 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of DPYD mRNA | decreases expression | 18042831 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DPYD mRNA | affects cotreatment|affects expression | 17602206 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DPYD mRNA | affects cotreatment|increases expression | 18544905 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of DPYD mRNA | decreases expression | 19638242 |
D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of DPYD mRNA | decreases expression | 15890375 |
D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of DPYD mRNA | decreases expression | 15890375 |
C067311 | docetaxel | [docetaxel co-treated with Fluorouracil] results in decreased expression of DPYD mRNA | affects cotreatment|decreases expression | 16557585 |
C067311 | docetaxel | docetaxel inhibits the reaction [Fluorouracil results in increased activity of DPYD protein] | decreases reaction|increases activity | 16557585 |
C067311 | docetaxel | docetaxel results in decreased activity of DPYD protein | decreases activity | 16557585 |
C067311 | docetaxel | docetaxel results in increased expression of DPYD protein | increases expression | 16557585 |
C067311 | docetaxel | Fluorouracil inhibits the reaction [docetaxel results in increased expression of DPYD protein] | decreases reaction|increases expression | 16557585 |
C025034 | doxifluridine | doxifluridine affects the expression of DPYD mRNA | affects expression | 18630517 |
C025034 | doxifluridine | DPYD protein affects the susceptibility to doxifluridine | affects response to substance | 16646564 |
C025034 | doxifluridine | DPYD protein results in decreased susceptibility to doxifluridine | decreases response to substance | 16734730 |
C025034 | doxifluridine | [Paclitaxel co-treated with doxifluridine] affects the expression of DPYD mRNA | affects cotreatment|affects expression | 18630517 |
D015251 | Epirubicin | DPYD protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin] | affects cotreatment|affects response to substance | 16646564 |
D005001 | Ethionine | Ethionine affects the expression of DPYD mRNA | affects expression | 19483382 |
D005472 | Fluorouracil | DPYD protein results in decreased susceptibility to Fluorouracil | decreases response to substance | 18612238 |
D005472 | Fluorouracil | Camptothecin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA] | decreases reaction|increases expression | 16568373 |
D005472 | Fluorouracil | [Cisplatin co-treated with Fluorouracil] results in decreased expression of DPYD mRNA | affects cotreatment|decreases expression | 15737843 |
D005472 | Fluorouracil | Cisplatin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA] | decreases reaction|increases expression | 16568373 |
D005472 | Fluorouracil | [docetaxel co-treated with Fluorouracil] results in decreased expression of DPYD mRNA | affects cotreatment|decreases expression | 16557585 |
D005472 | Fluorouracil | docetaxel inhibits the reaction [Fluorouracil results in increased activity of DPYD protein] | decreases reaction|increases activity | 16557585 |
D005472 | Fluorouracil | DPYD gene polymorphism affects the susceptibility to Fluorouracil | affects response to substance | 18443386 18299612 17121937 |
D005472 | Fluorouracil | DPYD gene polymorphism results in decreased metabolism of Fluorouracil | decreases metabolic processing | 15591715 18443386 |
D005472 | Fluorouracil | DPYD gene polymorphism results in increased susceptibility to Fluorouracil | increases response to substance | 17064846 19104657 |
D005472 | Fluorouracil | DPYD gene SNP affects the susceptibility to Fluorouracil | affects response to substance | 17046731 |
D005472 | Fluorouracil | DPYD intron polymorphism affects the susceptibility to Fluorouracil | affects response to substance | 15858133 |
D005472 | Fluorouracil | DPYD mRNA affects the susceptibility to Fluorouracil | affects response to substance | 18986760 |
D005472 | Fluorouracil | DPYD mRNA results in decreased susceptibility to Fluorouracil | decreases response to substance | 18383874 15246190 |
D005472 | Fluorouracil | DPYD mRNA results in increased susceptibility to Fluorouracil | increases response to substance | 15239142 |
D005472 | Fluorouracil | DPYD promoter modified form affects the susceptibility to Fluorouracil | affects response to substance | 16361556 |
D005472 | Fluorouracil | DPYD protein affects the degradation of Fluorouracil | affects degradation | 15858133 |
D005472 | Fluorouracil | DPYD protein affects the metabolism of Fluorouracil | affects metabolic processing | 18600527 15930747 |
D005472 | Fluorouracil | DPYD protein affects the susceptibility to Fluorouracil | affects response to substance | 15017333 15655543 18846242 19020767 15993511 18619742 18197934 |
D005472 | Fluorouracil | DPYD protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin] | affects cotreatment|affects response to substance | 16646564 |
D005472 | Fluorouracil | DPYD protein mutant form results in decreased metabolism of Fluorouracil | decreases metabolic processing | 16033824 |
D005472 | Fluorouracil | DPYD protein results in decreased susceptibility to Fluorouracil | decreases response to substance | 19105824 16282729 15890242 14689231 17377791 |
D005472 | Fluorouracil | DPYD protein results in increased degradation of Fluorouracil | increases degradation | 17046731 |
D005472 | Fluorouracil | DPYD protein results in increased metabolism of Fluorouracil | increases metabolic processing | 15591715 18225548 15993511 18075467 16033824 16115930 17064846 |
D005472 | Fluorouracil | Fluorouracil inhibits the reaction [docetaxel results in increased expression of DPYD protein] | decreases reaction|increases expression | 16557585 |
D005472 | Fluorouracil | Fluorouracil metabolite affects the activity of DPYD protein | affects activity | 16761622 |
D005472 | Fluorouracil | Fluorouracil results in decreased expression of DPYD mRNA | decreases expression | 19219653 15109396 17330233 |
D005472 | Fluorouracil | Fluorouracil results in increased activity of DPYD protein | increases activity | 16557585 |
D005472 | Fluorouracil | Fluorouracil results in increased expression of DPYD mRNA | increases expression | 16568373 18197934 |
D005472 | Fluorouracil | Fluorouracil results in increased expression of DPYD protein | increases expression | 15865071 |
D005472 | Fluorouracil | gimeracil affects the reaction [DPYD protein results in increased susceptibility to Fluorouracil] | affects reaction|increases response to substance | 15993511 |
D005472 | Fluorouracil | gimeracil inhibits the reaction [DPYD protein results in increased degradation of Fluorouracil] | decreases reaction|increases degradation | 19093184 |
D005472 | Fluorouracil | gimeracil inhibits the reaction [DPYD protein results in increased metabolism of Fluorouracil] | decreases reaction|increases metabolic processing | 15993511 |
D005472 | Fluorouracil | DPYD mRNA results in decreased susceptibility to Fluorouracil | decreases response to substance | 16525674 |
D005472 | Fluorouracil | DPYD protein affects the metabolism of Fluorouracil | affects metabolic processing | 16012767 |
D005472 | Fluorouracil | DPYD protein results in increased degradation of Fluorouracil | increases degradation | 17089033 18619742 19082440 |
C056507 | gemcitabine | [TYMP protein co-treated with DPYD protein] affects the susceptibility to gemcitabine | affects cotreatment|affects response to substance | 18728667 |
C104201 | gimeracil | gimeracil affects the reaction [DPYD protein results in increased susceptibility to Fluorouracil] | affects reaction|increases response to substance | 15993511 |
C104201 | gimeracil | gimeracil inhibits the reaction [DPYD protein results in increased degradation of Fluorouracil] | decreases reaction|increases degradation | 19093184 |
C104201 | gimeracil | gimeracil inhibits the reaction [DPYD protein results in increased metabolism of Fluorouracil] | decreases reaction|increases metabolic processing | 15993511 |
C104201 | gimeracil | gimeracil results in decreased activity of DPYD protein | decreases activity | 17699726 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which binds to DPYD promoter] | affects binding|affects cotreatment|increases reaction | 15705907 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of DPYD mRNA] | affects binding|affects cotreatment|increases expression|increases reaction | 15705907 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of DPYD mRNA | affects cotreatment|increases expression | 15705907 |
C051890 | irinotecan | DPYD protein results in decreased susceptibility to irinotecan | decreases response to substance | 16734730 |
C051890 | irinotecan | irinotecan metabolite results in decreased expression of DPYD mRNA | decreases expression | 15956246 |
C051890 | irinotecan | irinotecan results in decreased expression of DPYD mRNA | decreases expression | 15956246 |
C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DPYD mRNA | affects cotreatment|increases expression | 18544905 |
D008701 | Methapyrilene | Methapyrilene results in decreased expression of DPYD mRNA | decreases expression | 15890375 |
C008493 | methylselenic acid | methylselenic acid results in increased expression of DPYD mRNA | increases expression | 18548127 |
D009853 | Omeprazole | Omeprazole affects the expression of DPYD mRNA | affects expression | 19483382 |
C030110 | oxaliplatin | [TYMP protein co-treated with DPYD protein] affects the susceptibility to oxaliplatin | affects cotreatment|affects response to substance | 18728667 |
D017239 | Paclitaxel | Paclitaxel affects the expression of DPYD mRNA | affects expression | 18630517 |
D017239 | Paclitaxel | [Paclitaxel co-treated with doxifluridine] affects the expression of DPYD mRNA | affects cotreatment|affects expression | 18630517 |
D017239 | Paclitaxel | Paclitaxel results in decreased expression of DPYD mRNA | decreases expression | 16568373 |
C041786 | palm oil | palm oil results in decreased expression of DPYD mRNA | decreases expression | 18042831 |
D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of DPYD mRNA] | affects reaction|decreases expression | 19482888 |
D010634 | Phenobarbital | Phenobarbital results in decreased expression of DPYD mRNA | decreases expression | 19482888 |
D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in decreased expression of DPYD mRNA | decreases expression | 15890375 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DPYD mRNA | affects binding|decreases expression|increases activity | 19710929 |
C006253 | pirinixic acid | pirinixic acid affects the expression of DPYD mRNA | affects expression | 19483382 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of DPYD mRNA | decreases expression | 15890375 |
D011441 | Propylthiouracil | Propylthiouracil affects the expression of DPYD mRNA | affects expression | 19483382 |
C079198 | S 1 (combination) | S 1 (combination) results in increased expression of DPYD mRNA | increases expression | 18506536 |
D012643 | Selenium | Selenium results in decreased expression of DPYD mRNA | decreases expression | 19244175 |
D005641 | Tegafur | DPYD gene polymorphism affects the susceptibility to Tegafur | affects response to substance | 18537153 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of DPYD mRNA | decreases expression | 18796159 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which binds to DPYD promoter] | affects binding|affects cotreatment|increases reaction | 15705907 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of DPYD mRNA] | affects binding|affects cotreatment|increases expression|increases reaction | 15705907 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of DPYD mRNA | affects cotreatment|increases expression | 15705907 |
D013853 | Thioacetamide | Thioacetamide affects the expression of DPYD mRNA | affects expression | 19483382 |
D013941 | Thymine | DPYD protein results in increased degradation of Thymine | increases degradation | 18619742 |
D014415 | Tunicamycin | Tunicamycin results in decreased expression of DPYD mRNA | decreases expression | 17127020 |
D014498 | Uracil | DPYD protein results in increased degradation of Uracil | increases degradation | 18619742 |
C519688 | XELOX | DPYD protein affects the susceptibility to XELOX | affects response to substance | 16292536 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 6.38 | 6195326 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 6.38 | 15322242 14514962 11752688 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 2.98 | 18287403 | |
MESH:D058186 | Acute Kidney Injury | Cisplatin | 3.44 | 12690470 17670903 15814532 | |
MESH:D055371 | Acute Lung Injury | pirinixic acid | 2.58 | 18653653 | |
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 8.67 | 20127859 20464547 | |
MESH:D000230 | Adenocarcinoma | Cisplatin | 8.67 | 11798837 17638652 | |
MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 8.67 | 16033868 | |
MESH:D000230 | Adenocarcinoma | Fluorouracil | 8.67 | 17638652 | |
MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 17.17 | 3712494 | |
MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 17.17 | 16176798 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 17.17 | 6695378 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 17.17 | 10737359 6695378 | |
MESH:D000236 | Adenoma | Dimethylnitrosamine | 17.17 | 19555203 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 20.09 | 19052882 19061943 17162532 16434500 18056438 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 20.09 | 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 20.09 | 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 20.09 | 16835633 | |
MESH:D000686 | Amyloidosis | Diethylstilbestrol | 3.93 | 15469931 | |
MESH:D000740 | Anemia | Fluorouracil | 6.99 | 16511603 17963324 15504547 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 6.99 | 11748828 | |
MESH:D000799 | Angioedema | Acetaminophen | 3.25 | 10982225 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.50 | 19183758 | |
MESH:D001145 | Arrhythmias, Cardiac | Amiodarone | 3.30 | 18057881 18218290 20041841 | |
MESH:D001161 | Arteriosclerosis | Dietary Fats | 3.32 | 15238619 | |
MESH:D001281 | Atrial Fibrillation | Amiodarone | 3.46 | 19698954 18651412 | |
MESH:D001321 | Autistic Disorder | marker/mechanism | 21114665 | ||
MESH:D001321 | Autistic Disorder | Acetaminophen | 1.50 | 18445737 | |
MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 4.42 | 1440618 11289319 | |
MESH:D001778 | Blood Coagulation Disorders | Amiodarone | 47.88 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Benzbromarone | 47.88 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Clofibrate | 47.88 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Ethionine | 47.88 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Omeprazole | 47.88 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 47.88 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Propylthiouracil | 47.88 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 47.88 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Thioacetamide | 47.88 | 19483382 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.20 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.37 | 15746008 | |
MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 4.29 | 14601052 | |
MESH:D001859 | Bone Neoplasms | Paclitaxel | 4.03 | 15867366 | |
MESH:D001943 | Breast Neoplasms | marker/mechanism | 19020767 | ||
MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 11.32 | 20146248 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 11.32 | 20146248 17474063 | |
MESH:D001943 | Breast Neoplasms | capecitabine | 11.32 | 18473752 12972520 | |
MESH:D001943 | Breast Neoplasms | Cisplatin | 11.32 | 19526202 18382427 | |
MESH:D001943 | Breast Neoplasms | decitabine | 11.32 | 18320071 19208741 | |
MESH:D001943 | Breast Neoplasms | Dietary Fats | 11.32 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 11.32 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 11.32 | 17129689 15324884 | |
MESH:D001943 | Breast Neoplasms | docetaxel | 11.32 | 19526202 17369602 18628466 16495393 16264153 15567936 15692762 | |
MESH:D001943 | Breast Neoplasms | Epirubicin | 11.32 | 15093573 16642371 12006526 18511948 17388661 | |
MESH:D001943 | Breast Neoplasms | Fluorouracil | 11.32 | 15136595 16595493 19217205 16557594 16110121 18608205 18357371 | |
MESH:D001943 | Breast Neoplasms | gemcitabine | 11.32 | 17039268 18382427 | |
MESH:D001943 | Breast Neoplasms | Paclitaxel | 11.32 | 16115903 15136595 11325840 16273361 18234424 16244791 18223236 18323546 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 11.32 | 20435547 | |
MESH:D002276 | Carcinoid Tumor | Fluorouracil | 4.07 | 16051944 | |
MESH:D002277 | Carcinoma | Dimethylnitrosamine | 11.29 | 19555203 | |
MESH:D002277 | Carcinoma | Fluorouracil | 11.29 | 17121937 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 11.29 | 16835633 | |
MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 18019677 | ||
MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 29.10 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 29.10 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 29.10 | 7296757 3581430 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 29.10 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 29.10 | 21507988 12907637 12619106 | |
MESH:D006528 | Carcinoma, Hepatocellular | Benzbromarone | 29.10 | 1701930 | |
MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 29.10 | 17982673 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 29.10 | 20935162 19208518 19394651 16698587 16807293 16935385 19418558 18978308 19383236 16569478 3084413 19919837 20007298 20214788 19822196 16502159 3581430 17761372 21159647 17173139 18056438 20514400 11831363 16288022 19107877 16328049 19052882 19171122 18785209 17138121 18494052 19539802 17428255 17978847 16779866 17055752 16830150 18393292 10737359 20727157 16681979 18788625 19519916 18506893 18210153 16878318 20524982 19701751 20432363 10672840 17162532 20101231 20512989 16540662 19335982 18691550 20084675 18665156 18971187 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 29.10 | 15948411 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 29.10 | 16799960 18930000 17971768 17045692 17088986 16332177 | |
MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 29.10 | 16313753 | |
MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 29.10 | 20007298 17173139 20935162 6705139 1701930 | |
MESH:D006528 | Carcinoma, Hepatocellular | Thioacetamide | 29.10 | 17997003 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 10.94 | 16685392 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 10.94 | 16685392 12023789 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | docetaxel | 10.94 | 11894018 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | S 1 (combination) | 10.94 | 18212800 18347146 | |
MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 5.47 | 7296757 | |
MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 5.47 | 18695887 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 18.75 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 18.75 | 17066447 6189445 18337622 | |
MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 18.75 | 19215824 | |
MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 18.75 | 16033868 | |
MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 18.75 | 16757204 18986760 16280240 17066447 | |
MESH:D002294 | Carcinoma, Squamous Cell | S 1 (combination) | 18.75 | 15984520 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 18.75 | 18922899 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 2.02 | 18670907 18850075 16120746 | |
MESH:D002311 | Cardiomyopathy, Dilated | Amiodarone | 2.66 | 15710769 19225199 | |
MESH:D002341 | Carotid Artery Thrombosis | Amiodarone | 4.50 | 18974383 | |
MESH:D002386 | Cataract | Acetaminophen | 2.22 | 10977129 | |
MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 16.67 | 6135515 | |
MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 16.67 | 7505956 | |
MESH:D002471 | Cell Transformation, Neoplastic | Clofibrate | 16.67 | 1399818 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 16.67 | 12371664 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 16.67 | 2727394 7505956 17174075 21159647 | |
MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 3.68 | 4080065 | |
MESH:D002637 | Chest Pain | Omeprazole | 4.51 | 15447763 | |
MESH:D002659 | Child Development Disorders, Pervasive | marker/mechanism | 18252227 20844286 | ||
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 13.26 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 13.26 | 16835633 | |
MESH:D018281 | Cholangiocarcinoma | Thioacetamide | 13.26 | 18291259 | |
MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 10.81 | 9022650 19486331 | |
MESH:D002779 | Cholestasis | Cyclosporine | 10.81 | 19486331 | |
MESH:D002779 | Cholestasis | pirinixic acid | 10.81 | 19176532 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 1.83 | 8697196 12621046 16354765 15340226 15668235 | |
MESH:D003092 | Colitis | Selenium | 3.22 | 17936198 | |
MESH:D003108 | Colonic Diseases | Tegafur | 7.04 | 15006714 | |
MESH:D003110 | Colonic Neoplasms | marker/mechanism | 18652704 | ||
MESH:D003110 | Colonic Neoplasms | decitabine | 7.16 | 17616700 | |
MESH:D003110 | Colonic Neoplasms | Fluorouracil | 7.16 | 17172411 17725105 18772588 16510598 16340194 15001691 17287894 17018589 17016597 17169374 | |
MESH:D003110 | Colonic Neoplasms | irinotecan | 7.16 | 17287894 17725105 | |
MESH:D003110 | Colonic Neoplasms | oxaliplatin | 7.16 | 16024531 16510598 16004971 | |
MESH:D015179 | Colorectal Neoplasms | marker/mechanism | 15222106 15814641 17047489 17611699 19020767 | ||
MESH:D015179 | Colorectal Neoplasms | Azacitidine | 11.30 | 19934284 | |
MESH:D015179 | Colorectal Neoplasms | capecitabine | 11.30 | 18448328 18473752 | |
MESH:D015179 | Colorectal Neoplasms | Cisplatin | 11.30 | 15273666 | |
MESH:D015179 | Colorectal Neoplasms | decitabine | 11.30 | 18981723 | |
MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 11.30 | 20501625 18288408 17401013 17255274 17454858 17094418 15148649 15289873 18509181 17594712 16303861 14970324 18802399 18383874 16331619 17016601 17695437 18949393 16391804 16282729 16524972 18448328 | |
MESH:D015179 | Colorectal Neoplasms | irinotecan | 11.30 | 15273666 16391804 18509181 17159606 16303861 17454858 18259882 | |
MESH:D015179 | Colorectal Neoplasms | oxaliplatin | 11.30 | 18448328 17695437 17255274 18509181 17594712 17401013 | |
MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 11.30 | 18802399 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.57 | 17141729 14669216 | |
MESH:D003329 | Coronary Vasospasm | capecitabine | 5.25 | 17465463 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 1.23 | 10048152 20055451 15322242 | |
MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 4.00 | 12952375 16002989 | |
MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 9.00 | 18551238 | |
MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 9.00 | 18551238 | |
MESH:D007644 | Darier Disease | Fluorouracil | 4.21 | 16733453 | |
MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 2.27 | 18759878 2524372 8156756 14531868 12868966 11906362 8970840 11298694 | |
MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 2.13 | 18249437 | |
MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 2.96 | 3621924 2952479 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 3.62 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 3.62 | 17107852 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 24.93 | 18551238 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 24.93 | 21346803 18551238 | |
MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 24.93 | 9328219 7440962 6679447 18289764 18692083 1440618 9022650 18648102 9653073 16192314 11289319 6482804 8291058 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 24.93 | 18713872 14725611 19420014 17562736 11743745 11461765 11739529 16177239 16393943 19416960 16485898 16081117 11529661 14986274 12392966 11834606 12594235 17522070 19164858 15968718 19370779 10774834 15619225 16781746 14550746 16227642 19923254 12705907 2444490 18071297 12540782 16109766 19739265 12958197 12153990 17906064 10915739 19085960 11287661 11421492 10663392 | |
MESH:D056486 | Drug-Induced Liver Injury | Amiodarone | 24.93 | 15265979 18218290 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 24.93 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 24.93 | 8172417 | |
MESH:D056486 | Drug-Induced Liver Injury | Selenium | 24.93 | 15131321 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 24.93 | 20420201 | |
MESH:D056486 | Drug-Induced Liver Injury | Thioacetamide | 24.93 | 12963478 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 3.50 | 19426721 | |
MESH:D004362 | Drug Toxicity | Cisplatin | 6.70 | 12231392 12649298 19839026 15033597 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 6.70 | 11462148 | |
MESH:D004381 | Duodenal Ulcer | Omeprazole | 3.78 | 17151854 21218061 16613094 15991576 | |
MESH:D050171 | Dyslipidemias | Clofibrate | 7.38 | 16707586 | |
MESH:D050171 | Dyslipidemias | Dietary Fats | 7.38 | 18367378 | |
MESH:D004421 | Dystonia | Phenobarbital | 3.46 | 1851702 | |
MESH:D004487 | Edema | pirinixic acid | 8.49 | 12083418 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 8.49 | 12711302 11000095 | |
MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 8.49 | 11698051 9599246 15177302 8273558 16716910 8113982 7812673 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 3.31 | 18230668 16714409 15322242 | |
MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 4.52 | 19294695 | |
MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 4.11 | 16402032 | |
MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 3.07 | 15700306 16804899 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.52 | 10568697 9294722 | |
MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 3.54 | 3659116 | |
MESH:D004828 | Epilepsies, Partial | Phenobarbital | 3.28 | 3922381 11558140 | |
MESH:D004827 | Epilepsy | Phenobarbital | 2.57 | 20417680 | |
MESH:D004832 | Epilepsy, Absence | Phenobarbital | 3.05 | 6401628 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 3.68 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 3.44 | 3659116 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.52 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 18.32 | 3581430 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 18.32 | 16530937 | |
MESH:D004938 | Esophageal Neoplasms | Cisplatin | 18.32 | 17638652 15173087 16481741 15464296 16785472 | |
MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 18.32 | 17016578 | |
MESH:D004938 | Esophageal Neoplasms | docetaxel | 18.32 | 16337965 | |
MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 18.32 | 16785472 17638652 16337965 16481741 15173087 | |
MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 18.32 | 16481741 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.57 | 11564622 | |
MESH:D005218 | Fat Necrosis | Thioacetamide | 5.12 | 16456712 | |
MESH:D005234 | Fatty Liver | Amiodarone | 23.97 | 14986274 | |
MESH:D005234 | Fatty Liver | Clofibrate | 23.97 | 19224547 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 23.97 | 19224547 | |
MESH:D005234 | Fatty Liver | Dietary Fats | 23.97 | 17967931 19004024 19551842 18296743 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 23.97 | 20387270 21071580 | |
MESH:D005234 | Fatty Liver | pirinixic acid | 23.97 | 19236843 20131406 | |
MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 3.28 | 16611131 16002989 16513791 15751030 16534752 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.89 | 11858732 | |
MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 4.42 | 6705139 | |
MESH:D005355 | Fibrosis | Cyclosporine | 11.44 | 12639820 12168785 | |
MESH:D005355 | Fibrosis | Dietary Fats | 11.44 | 18296743 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 11.44 | 20067830 | |
MESH:D005706 | Gallbladder Neoplasms | S 1 (combination) | 5.21 | 19093184 | |
MESH:D005756 | Gastritis | Acetaminophen | 3.08 | 16983495 | |
MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 4.36 | 16452187 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 3.63 | 8708960 | |
MESH:D005910 | Glioma | Fluorouracil | 2.61 | 16145905 | |
MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 3.50 | 7505956 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.00 | 10696789 | |
MESH:D006258 | Head and Neck Neoplasms | marker/mechanism | 19020767 | ||
MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 15.17 | 15464296 15102660 | |
MESH:D006258 | Head and Neck Neoplasms | decitabine | 15.17 | 19215824 | |
MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 15.17 | 15162350 15102660 18337622 | |
MESH:D006258 | Head and Neck Neoplasms | S 1 (combination) | 15.17 | 18607998 15984520 | |
MESH:D034381 | Hearing Loss | Cisplatin | 3.80 | 19898482 | |
MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.93 | 15464296 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 5.32 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 5.32 | 11294989 10048152 | |
MESH:D006333 | Heart Failure | pirinixic acid | 5.68 | 20558911 | |
MESH:D006333 | Heart Failure | Selenium | 5.68 | 17162251 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.84 | 15720958 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.81 | 11000095 | |
MESH:D006501 | Hepatic Encephalopathy | Thioacetamide | 4.05 | 17276928 15929193 18665440 | |
MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 7.62 | 6705139 | |
MESH:D006505 | Hepatitis | Thioacetamide | 7.62 | 16456712 | |
MESH:D006529 | Hepatomegaly | Amiodarone | 16.03 | 15265979 | |
MESH:D006529 | Hepatomegaly | Phenobarbital | 16.03 | 16109766 | |
MESH:D006529 | Hepatomegaly | pirinixic acid | 16.03 | 19176532 16221962 19772884 18467677 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 16.03 | 12621046 16120746 15340226 | |
MESH:D006689 | Hodgkin Disease | Cisplatin | 6.65 | 16200630 16170182 | |
MESH:D006689 | Hodgkin Disease | Epirubicin | 6.65 | 18180244 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.45 | 15340226 16354765 8697196 18606429 16959395 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 6.50 | 16870215 | |
MESH:D006930 | Hyperalgesia | oxaliplatin | 6.50 | 17418472 | |
MESH:D006937 | Hypercholesterolemia | Amiodarone | 7.43 | 9751232 8137927 | |
MESH:D006937 | Hypercholesterolemia | Dietary Fats | 7.43 | 21332399 | |
MESH:D006943 | Hyperglycemia | pirinixic acid | 2.68 | 20558911 | |
MESH:D006949 | Hyperlipidemias | Dietary Fats | 3.08 | 21332399 | |
MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 8.94 | 15034207 | |
MESH:D006965 | Hyperplasia | Diethylstilbestrol | 8.94 | 14722030 12960047 | |
MESH:D006973 | Hypertension | Cyclosporine | 4.09 | 10903974 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 4.09 | 18670907 18850075 | |
MESH:D007021 | Hypospadias | Diethylstilbestrol | 4.01 | 16002989 | |
MESH:D007037 | Hypothyroidism | Amiodarone | 9.72 | 17991464 18020914 | |
MESH:D007037 | Hypothyroidism | Propylthiouracil | 9.72 | 8137927 18031379 | |
MESH:D007246 | Infertility | Diethylstilbestrol | 3.80 | 15036965 | |
MESH:D007248 | Infertility, Male | decitabine | 2.81 | 17581917 | |
MESH:D007249 | Inflammation | Dietary Fats | 9.23 | 20412841 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 9.23 | 18785209 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 9.23 | 12200463 12878042 | |
MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 9.23 | 11698051 8273558 7562506 7812673 15177302 | |
MESH:D007251 | Influenza, Human | Selenium | 3.60 | 16624496 | |
MESH:D007333 | Insulin Resistance | Dietary Fats | 5.91 | 18457598 11836018 | |
MESH:D007333 | Insulin Resistance | pirinixic acid | 5.91 | 16306350 | |
MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 4.42 | 8074119 9022650 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 2.81 | 16580747 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.85 | 15604871 | |
MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 4.55 | 15464296 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 7.96 | 12587719 15629191 | |
MESH:D007674 | Kidney Diseases | Cisplatin | 7.96 | 12649298 18289764 15190930 12231392 19839026 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 7.96 | 18776723 10903974 8314463 | |
MESH:D007676 | Kidney Failure, Chronic | Selenium | 3.36 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 22.91 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 22.91 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 22.91 | 6582329 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 22.91 | 12371664 | |
MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 22.91 | 15003126 16762066 14681315 | |
MESH:D007680 | Kidney Neoplasms | Fluorouracil | 22.91 | 16985049 | |
MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 4.20 | 11231351 | |
MESH:D007805 | Language Development Disorders | marker/mechanism | 21114665 | ||
MESH:D007859 | Learning Disorders | Diethylstilbestrol | 3.50 | 17184923 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Omeprazole | 3.62 | 19248655 | |
MESH:D007938 | Leukemia | Azacitidine | 5.69 | 19148494 | |
MESH:D007938 | Leukemia | decitabine | 5.69 | 19235587 18980019 | |
MESH:D007951 | Leukemia, Myeloid | Azacitidine | 8.16 | 19077051 | |
MESH:D007951 | Leukemia, Myeloid | decitabine | 8.16 | 19117987 17236224 18454857 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 3.85 | 18720364 17596541 | |
MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 3.85 | 18206229 17679729 19387464 18704418 19010910 18460780 | |
MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.87 | 18055864 | |
MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 4.65 | 19299654 | |
MESH:D008064 | Lipidoses | Amiodarone | 3.08 | 15342952 17567588 | |
MESH:D008080 | Liposarcoma | Paclitaxel | 4.28 | 17353645 | |
MESH:D008103 | Liver Cirrhosis | Dietary Fats | 8.99 | 18296743 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 8.99 | 20032147 19638242 18665156 18407596 18522880 | |
MESH:D008103 | Liver Cirrhosis | Phenobarbital | 8.99 | 21047994 | |
MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 2.81 | 9327722 15034207 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 4.21 | 18371158 15577212 17465448 15504291 18237412 15723089 15339415 18637143 17881167 17196135 15081153 17203207 18364076 14568256 16270385 15138612 15763062 16544323 17432682 18210741 17640959 17724770 15086199 15798949 14659978 18629640 15099470 15591649 15842777 17534399 12918455 18567088 15733078 16603200 17719030 16009107 12925901 16627068 15479170 15161499 15366600 16570917 17348192 15298665 16042886 15793283 15864749 16169303 14709902 15744066 17201889 17198567 15571005 18239293 17036385 14643895 15067225 18095165 15492853 15369754 17666798 15942678 14726149 15383259 18672772 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 4.21 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 4.21 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Thioacetamide | 4.21 | 18615449 15288472 10677585 15716488 12679928 15095483 16126171 18031379 18416461 11682029 15316131 15474484 16489207 11172339 18263696 18295389 18395095 17355460 17050028 16343077 15334695 17629604 15465738 15078482 16097051 15158331 12891558 16248980 17127702 17292413 18606216 15362042 14739098 18458672 12531686 18380797 15075984 12175628 18032466 16098781 11481614 16511523 12557150 15288473 12085344 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 7.80 | 11587558 12969438 12587719 19014921 16610002 19460945 16611625 19784758 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 7.80 | 17034775 | |
MESH:D008107 | Liver Diseases | Phenobarbital | 7.80 | 19363144 | |
MESH:D008107 | Liver Diseases | Thioacetamide | 7.80 | 16337175 15158337 18374380 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 13.40 | 17185352 16871587 | |
MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 13.40 | 17457977 | |
MESH:D017114 | Liver Failure, Acute | Thioacetamide | 13.40 | 15313186 17276928 15633222 12479984 | |
MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 48.87 | 7678174 | |
MESH:D008113 | Liver Neoplasms | 2-nitrofluorene | 48.87 | 15890375 | |
MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 48.87 | 15890375 | |
MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 48.87 | 18177683 15890375 2125692 9163691 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 48.87 | 20195826 21137059 | |
MESH:D008113 | Liver Neoplasms | Clofibric Acid | 48.87 | 17602206 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 48.87 | 20137499 18644402 12771043 2422723 19690152 19551842 19294768 20583210 12112319 20434301 21278145 20118626 19426721 18978307 19812893 16942905 20452335 20501860 19499222 10737359 19638242 19090486 20101389 19427195 21071580 19255062 18648771 20492335 18977376 19996281 19642983 19850985 21167192 21047994 2862719 19833225 19254457 15885732 15175105 18754104 19073162 20405173 19256749 9163691 | |
MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 48.87 | 15890375 16712894 | |
MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 48.87 | 15890375 3113478 | |
MESH:D008113 | Liver Neoplasms | Fluorouracil | 48.87 | 15113037 17045692 18383874 16603448 | |
MESH:D008113 | Liver Neoplasms | Methapyrilene | 48.87 | 15890375 | |
MESH:D008113 | Liver Neoplasms | Phenobarbital | 48.87 | 21047994 19812893 8742319 19482888 19073162 15975961 | |
MESH:D008113 | Liver Neoplasms | Piperonyl Butoxide | 48.87 | 19690152 18648771 15890375 20101389 | |
MESH:D008113 | Liver Neoplasms | pirinixic acid | 48.87 | 20007298 15890375 16377806 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 48.87 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 26.50 | 2876784 6135515 2876786 | |
MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 26.50 | 598648 3712494 1399818 6587162 | |
MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 26.50 | 8603461 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 26.50 | 18079962 19519916 19009564 18775883 18544905 18164116 16267830 17854601 19539802 19004024 9362446 21159647 16842330 18253720 18308698 3124819 18093689 19126423 17942915 2563599 17174075 18282651 | |
MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 26.50 | 1848544 15603536 6150874 | |
MESH:D008114 | Liver Neoplasms, Experimental | kojic acid | 26.50 | 18544905 | |
MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 26.50 | 17172636 18308698 1399818 2563599 6150874 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 26.50 | 12151625 | |
MESH:D008133 | Long QT Syndrome | Amiodarone | 3.13 | 17391786 15350150 11989578 | |
MESH:D008171 | Lung Diseases | Amiodarone | 2.97 | 12587719 | |
MESH:D017563 | Lung Diseases, Interstitial | Amiodarone | 3.89 | 18516814 | |
MESH:D008175 | Lung Neoplasms | marker/mechanism | 19020767 | ||
MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 18.08 | 17139156 12438228 16401635 15172992 15893417 9255578 18813816 14755239 18508827 19931552 16061637 | |
MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 18.08 | 14755239 | |
MESH:D008175 | Lung Neoplasms | Azacitidine | 18.08 | 21224363 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 18.08 | 20464547 17053015 18816296 18520028 18569708 6695378 20869020 20135361 20064080 | |
MESH:D008175 | Lung Neoplasms | Cisplatin | 18.08 | 11798837 6189445 17225452 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 18.08 | 6695378 20970405 20512841 21163286 | |
MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 18.08 | 16061637 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Fluorouracil | 18.08 | 15246190 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 18.08 | 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 18.08 | 11807781 | |
MESH:D008175 | Lung Neoplasms | XELOX | 18.08 | 18418008 | |
MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 4.21 | 15086387 | |
MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 4.57 | 15166399 | |
MESH:D008223 | Lymphoma | decitabine | 6.30 | 19470736 | |
MESH:D008223 | Lymphoma | Diethylstilbestrol | 6.30 | 15700306 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 3.61 | 14749477 | |
MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.92 | 16002989 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 5.02 | 15318939 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 5.02 | 8985016 | |
MESH:D008545 | Melanoma | Carboplatin | 10.71 | 11712820 12040289 16342250 16225601 | |
MESH:D008545 | Melanoma | Cisplatin | 10.71 | 12883367 12374674 17023156 12393984 15577323 11135225 17761969 18176117 18332650 16809738 16432458 18505091 16248763 | |
MESH:D008545 | Melanoma | decitabine | 10.71 | 17785578 16505122 | |
MESH:D008545 | Melanoma | docetaxel | 10.71 | 12417787 | |
MESH:D008545 | Melanoma | Epirubicin | 10.71 | 16642371 | |
MESH:D008545 | Melanoma | Paclitaxel | 10.71 | 12025231 16342250 12040289 | |
MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 4.19 | 15990972 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 3.00 | 19513568 | |
MESH:D008654 | Mesothelioma | Cisplatin | 5.46 | 17638057 | |
MESH:D008654 | Mesothelioma | Selenium | 5.46 | 15107826 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 4.19 | 16801185 | |
MESH:D009006 | Monosomy | Azacitidine | 5.49 | 19299654 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 7.01 | 16381670 | |
MESH:D009062 | Mouth Neoplasms | Fluorouracil | 7.01 | 16757204 18986760 | |
MESH:D052016 | Mucositis | irinotecan | 4.42 | 17159606 | |
MESH:D009101 | Multiple Myeloma | Azacitidine | 9.84 | 18443271 19549372 | |
MESH:D009101 | Multiple Myeloma | decitabine | 9.84 | 18172295 | |
MESH:D009101 | Multiple Myeloma | Paclitaxel | 9.84 | 14749477 | |
MESH:D009135 | Muscular Diseases | pirinixic acid | 2.94 | 16239165 | |
MESH:D009181 | Mycoses | Amiodarone | 4.31 | 12754197 17974566 | |
MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 6.62 | 17611569 19805378 17596541 18720364 | |
MESH:D009190 | Myelodysplastic Syndromes | decitabine | 6.62 | 16882708 19010910 18608210 19157545 | |
MESH:D009203 | Myocardial Infarction | pirinixic acid | 1.88 | 19151258 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.55 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 2.49 | 16411023 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 3.89 | 17484760 | |
MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 8.41 | 18551238 | |
MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 8.41 | 18551238 7678174 | |
MESH:D009362 | Neoplasm Metastasis | marker/mechanism | 17611699 | ||
MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 15.08 | 3581430 | |
MESH:D009362 | Neoplasm Metastasis | capecitabine | 15.08 | 12972520 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 15.08 | 9029167 3581430 | |
MESH:D009362 | Neoplasm Metastasis | irinotecan | 15.08 | 18259882 | |
MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 15.08 | 15867366 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 22.75 | 11141357 | |
MESH:D009369 | Neoplasms | capecitabine | 22.75 | 16374040 | |
MESH:D009369 | Neoplasms | Carboplatin | 22.75 | 18854779 17925555 | |
MESH:D009369 | Neoplasms | Cisplatin | 22.75 | 16773208 | |
MESH:D009369 | Neoplasms | decitabine | 22.75 | 19116145 19470736 17925555 | |
MESH:D009369 | Neoplasms | Diethylstilbestrol | 22.75 | 15313581 | |
MESH:D009369 | Neoplasms | Fluorouracil | 22.75 | 18239605 18600527 16928823 | |
MESH:D009369 | Neoplasms | pirinixic acid | 22.75 | 17405874 | |
MESH:D009395 | Nephritis, Interstitial | Cisplatin | 3.90 | 15464296 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.85 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 2.79 | 19348381 18481113 | |
MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 7.80 | 11399458 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 7.80 | 14600291 | |
MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 2.52 | 6679447 | |
MESH:D009447 | Neuroblastoma | Cisplatin | 6.12 | 8761367 | |
MESH:D009447 | Neuroblastoma | irinotecan | 6.12 | 8761367 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 6.59 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 6.59 | 20387270 | |
MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 15.84 | 12837982 | |
MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 15.84 | 8761367 | |
MESH:D017599 | Neuroectodermal Tumors | irinotecan | 15.84 | 8761367 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.52 | 20387270 | |
MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 3.03 | 16436463 | |
MESH:D052556 | Niemann-Pick Disease, Type C | Clofibrate | 4.37 | 9802331 | |
MESH:D009765 | Obesity | Dietary Fats | 3.82 | 18674790 20518802 19632207 17217161 20132043 21332399 18457598 16723640 11836018 | |
MESH:D009765 | Obesity | pirinixic acid | 3.82 | 20558911 | |
MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 12.12 | 12819281 16049721 | |
MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 12.12 | 16049721 | |
MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 12.12 | 6482804 4026338 | |
MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 4.42 | 3988306 | |
MESH:D010014 | Osteolysis | Paclitaxel | 4.40 | 15867366 | |
MESH:D010018 | Osteomalacia | Phenobarbital | 3.78 | 17016548 | |
MESH:D010051 | Ovarian Neoplasms | Cisplatin | 6.77 | 17225452 15464296 19769630 6897625 | |
MESH:D010051 | Ovarian Neoplasms | decitabine | 6.77 | 19259094 19331143 | |
MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 6.77 | 11161223 | |
MESH:D010146 | Pain | Acetaminophen | 1.94 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | marker/mechanism | 17443278 19020767 | ||
MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 24.99 | 12384795 | |
MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 24.99 | 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | decitabine | 24.99 | 19294695 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 24.99 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 24.99 | 16500647 16929163 15113037 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | gemcitabine | 24.99 | 18992248 16929163 11504793 18383843 17440100 | |
MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 24.99 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 24.99 | 15976015 | |
MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 7.51 | 7296757 | |
MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 7.51 | 18922899 12065085 8330346 18404319 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.65 | 12520081 | |
MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 3.76 | 15464296 | |
MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 3.87 | 6228378 | |
MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 4.57 | 14722030 | |
MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 4.10 | 16977796 15687265 | |
MESH:D010954 | Plasmacytoma | Selenium | 4.29 | 15087411 | |
MESH:D010997 | Pleural Neoplasms | Cisplatin | 4.75 | 17638057 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.00 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 12.41 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 12.41 | 2563599 | |
MESH:D011230 | Precancerous Conditions | Phenobarbital | 12.41 | 2563599 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 7.64 | 17184923 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 7.64 | 11118676 11222880 11896295 11399792 | |
MESH:D055728 | Primary Myelofibrosis | decitabine | 4.16 | 17616702 | |
MESH:D011471 | Prostatic Neoplasms | Azacitidine | 1.99 | 18324645 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 1.99 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 1.99 | 17136230 15046698 15846301 | |
MESH:D011471 | Prostatic Neoplasms | docetaxel | 1.99 | 18824434 16520278 19103299 16644109 | |
MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 1.99 | 19082440 18626508 | |
MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 1.99 | 16205645 | |
MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 1.99 | 17136230 16356831 16729912 17172428 | |
MESH:D019310 | Pseudolymphoma | Phenobarbital | 3.90 | 12752131 | |
MESH:D011565 | Psoriasis | Cyclosporine | 2.00 | 16882103 | |
MESH:D011658 | Pulmonary Fibrosis | Amiodarone | 2.60 | 11597910 12490602 12832656 | |
MESH:D011686 | Purine-Pyrimidine Metabolism, Inborn Errors | marker/mechanism | 15571261 16151913 | ||
MESH:D012004 | Rectal Neoplasms | Fluorouracil | 3.51 | 16160472 18286688 18722050 15538739 | |
MESH:D051437 | Renal Insufficiency | Cisplatin | 3.84 | 15464296 | |
MESH:D015427 | Reperfusion Injury | pirinixic acid | 2.07 | 19058328 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.28 | 18990726 | |
MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 2.93 | 3692021 | |
MESH:D012208 | Rhabdomyosarcoma | decitabine | 3.86 | 19155313 | |
MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 3.88 | 14601052 | |
MESH:D012640 | Seizures | 2,4-dinitrotoluene | 7.43 | 18551238 | |
MESH:D012640 | Seizures | 2,6-dinitrotoluene | 7.43 | 18551238 | |
MESH:D012640 | Seizures | Phenobarbital | 7.43 | 3137016 16876388 4039156 11442880 | |
MESH:D003294 | Seizures, Febrile | Phenobarbital | 4.24 | 6407741 | |
OMIM:609620 | SHORT QT SYNDROME 1 | Amiodarone | 4.50 | 18724381 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 7.68 | 10029692 19755658 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 7.68 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 7.68 | 8330346 8985016 18404319 11807781 12065085 | |
MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 4.75 | 15464296 | |
MESH:D013088 | Spermatocele | Diethylstilbestrol | 4.12 | 16709447 16002989 | |
MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 4.67 | 12587719 | |
MESH:D013272 | Stomach Diseases | Omeprazole | 4.03 | 18545984 | |
MESH:D013274 | Stomach Neoplasms | marker/mechanism | 15837757 17089033 18652704 | ||
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 17.94 | 20155912 2093021 | |
MESH:D013274 | Stomach Neoplasms | Cisplatin | 17.94 | 15958060 17522103 18396642 | |
MESH:D013274 | Stomach Neoplasms | decitabine | 17.94 | 19037991 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 17.94 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 17.94 | 16033868 | |
MESH:D013274 | Stomach Neoplasms | docetaxel | 17.94 | 16557585 | |
MESH:D013274 | Stomach Neoplasms | Fluorouracil | 17.94 | 18396642 17522103 19015929 16424979 17172411 17498489 18567086 15786421 19084572 16951190 | |
MESH:D013274 | Stomach Neoplasms | irinotecan | 17.94 | 15723263 | |
MESH:D013274 | Stomach Neoplasms | Paclitaxel | 17.94 | 18396642 18506536 | |
MESH:D013274 | Stomach Neoplasms | S 1 (combination) | 17.94 | 16557585 18506536 18553229 | |
MESH:D013274 | Stomach Neoplasms | Tegafur | 17.94 | 18537153 | |
MESH:D013276 | Stomach Ulcer | Amiodarone | 5.87 | 18087811 | |
MESH:D013276 | Stomach Ulcer | Omeprazole | 5.87 | 18237397 16755016 10750652 11906479 15991576 17977527 | |
MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 5.23 | 12837982 | |
MESH:D013610 | Tachycardia | Amiodarone | 3.74 | 11238279 | |
MESH:D017180 | Tachycardia, Ventricular | Amiodarone | 3.64 | 19225199 | |
MESH:D024801 | Tauopathies | Camptothecin | 9.90 | 16930453 | |
MESH:D024801 | Tauopathies | Paclitaxel | 9.90 | 16930453 | |
MESH:D013736 | Testicular Neoplasms | Cisplatin | 4.09 | 15464296 17225452 | |
MESH:D013959 | Thyroid Diseases | Amiodarone | 10.07 | 19731979 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 10.07 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 17.70 | 6582329 3712494 7505956 6587162 1399818 | |
MESH:D013964 | Thyroid Neoplasms | decitabine | 17.70 | 17967635 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 17.70 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 17.70 | 1399818 | |
MESH:D013964 | Thyroid Neoplasms | Propylthiouracil | 17.70 | 15710170 | |
MESH:D013971 | Thyrotoxicosis | Amiodarone | 4.29 | 19584973 18020914 | |
MESH:D014062 | Tongue Neoplasms | Fluorouracil | 3.48 | 16280240 | |
MESH:D016171 | Torsades de Pointes | Amiodarone | 3.61 | 17467628 11989578 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 23.82 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 23.82 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 23.82 | 8074119 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 23.82 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 23.82 | 15464296 12973940 17225452 | |
MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 23.82 | 17616700 19087683 | |
MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 23.82 | 16712894 16452187 17306315 | |
MESH:D001749 | Urinary Bladder Neoplasms | Uracil | 23.82 | 7505956 | |
MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 10.05 | 10091137 | |
MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 10.05 | 10091137 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.44 | 10982225 | |
MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 13.02 | 16803524 | |
MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 13.02 | 16175088 | |
MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 13.02 | 16803524 | |
MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 4.57 | 14652134 | |
MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 3.52 | 15809267 16690809 | |
MESH:D014604 | Uveal Neoplasms | decitabine | 4.32 | 17785578 | |
MESH:D014605 | Uveitis | Cyclosporine | 3.39 | 1336536 | |
MESH:D014625 | Vaginal Neoplasms | Cisplatin | 9.19 | 15577323 | |
MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 9.19 | 16513791 16002989 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.00 | 12125929 | |
MESH:D014839 | Vomiting | Cisplatin | 4.12 | 11897121 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.65 | 15886252 | |
MESH:D015430 | Weight Gain | Dietary Fats | 3.24 | 16723640 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 3.85 | 17120751 |
Pathway ID | Pathway Name |
---|---|
KEGG:00410 | beta-Alanine metabolism |
KEGG:00983 | Drug metabolism - other enzymes |
KEGG:01100 | Metabolic pathways |
REACT:1698 | Metabolism of nucleotides |
KEGG:00770 | Pantothenate and CoA biosynthesis |
KEGG:00240 | Pyrimidine metabolism |
No data |
Releated disease ID | Related disease Name |
---|---|
PA445113 | Neutropenia |
PA443622 | Carcinoma, Non-Small-Cell Lung |
PA444818 | Lung Neoplasms |
PA151958591 | Esophogeal Neoplasms |
PA443560 | Breast Neoplasms |
PA153906318 | Autism Spectrum Disorder |
PA444352 | Head and Neck Neoplasms |
PA445048 | Nausea |
PA446051 | Vomiting |
PA443937 | Drug Toxicity |
PA444773 | Leukopenia |
PA444750 | Leukemia |
PA446108 | Colorectal Neoplasms |
PA128406957 | 5-fluorouracil associated toxicity |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
PA444257 | Gastrointestinal Neoplasms |
PA444101 | Esophageal Neoplasms |
PA447242 | epithelial cancers |
PA445062 | Neoplasms |
PA444929 | Mental Retardation |
PA445629 | Seizures |
Releated drug ID | Related drug Name |
---|---|
PA130232992 | bevacizumab |
PA449383 | docetaxel |
PA452620 | tegafur |
PA449014 | cisplatin |
PA450198 | leucovorin |
PA131285527 | oxaliplatin |
PA164713220 | Pyrimidine analogues |
PA131625240 | raltitrexed |
PA450428 | methotrexate |
PA448771 | capecitabine |
PA450085 | irinotecan |
PA450379 | mercaptopurine |
PA128406956 | fluorouracil |
PA448365 | amifostine |
PA448803 | carboplatin |
PA450761 | paclitaxel |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB02303 | - | (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione | |
DB02338 | - | Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate | |
DB03048 | - | 6-Carboxymethyluracil | |
DB03147 | - | Flavin-Adenine Dinucleotide | |
DB03247 | - | Riboflavin Monophosphate | Vitamin B Complex |
DB03419 | - | Uracil | |
DB03554 | - | 5-Iodouracil |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00544 | substrate | Fluorouracil | Antineoplastic Agents;Antimetabolites;Immunosuppressive Agents;Antimetabolites, Antineoplastic |
DB01101 | substrate | Capecitabine | Antineoplastic Agents;Antimetabolites;Prodrugs;Antimetabolites, Antineoplastic |
No data |
No data |